XML 45 R29.htm IDEA: XBRL DOCUMENT v3.24.1
Share-based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Fair value of Options Granted Under Weighted Average Assumptions

The fair value of each option granted during the period was estimated on the date of grant using the following weighted average assumptions:

 

2023

 

 

2022

 

Expected volatility

 

 

92

%

 

 

81

%

Expected term in years

 

 

6

 

 

 

6

 

Risk-free interest rate

 

 

3.6

%

 

 

1.7

%

Dividend yield

 

 

0

%

 

 

0

%

Summary of Option Activity

A summary of option activity for 2023 is presented below:

 

Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2022

 

 

6,148,447

 

 

$

1.97

 

 

 

 

 

 

 

Granted

 

 

1,002,743

 

 

 

2.28

 

 

 

 

 

 

 

Exercised

 

 

(105,187

)

 

 

0.22

 

 

 

 

 

 

 

Forfeited

 

 

(61,883

)

 

 

2.94

 

 

 

 

 

 

 

Expired

 

 

(38,404

)

 

 

3.01

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

6,945,716

 

 

 

2.03

 

 

 

7.32

 

 

$

2,227,555

 

Vested or expected to vest at December 31, 2023

 

 

6,945,716

 

 

 

2.03

 

 

 

7.32

 

 

$

2,227,555

 

Exercisable at December 31, 2023

 

 

3,999,908

 

 

$

1.44

 

 

 

6.56

 

 

$

2,227,545

 

Summary of Non-vested Stock Activity

A summary of non-vested stock activity for 2023 is presented below:

 

Nonvested
Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Outstanding at December 31, 2022

 

 

726,163

 

 

$

3.01

 

Granted

 

 

1,563,324

 

 

 

1.66

 

Vested

 

 

(804,234

)

 

 

2.15

 

Forfeited

 

 

(695,750

)

 

 

3.03

 

Outstanding at December 31, 2023

 

 

789,503

 

 

$

1.18

 

Summary of Share-based Compensation Expense The impact on the Company’s results of operations from share-based compensation for the year ended December 31, 2023 and 2022, was as follows (in thousands):

 

2023

 

 

2022

 

Research and development

 

$

541

 

 

$

435

 

General and administrative

 

 

3,289

 

 

 

2,592

 

Total share-based compensation expense

 

$

3,830

 

 

$

3,027